PMID- 30682248 OWN - NLM STAT- MEDLINE DCOM- 20200622 LR - 20200622 IS - 1520-4804 (Electronic) IS - 0022-2623 (Linking) VI - 62 IP - 13 DP - 2019 Jul 11 TI - Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs). PG - 5944-5978 LID - 10.1021/acs.jmedchem.8b01520 [doi] AB - Chronic obstructive pulmonary disease (COPD) is a very common and frequently fatal airway disease. Current therapies for COPD depend mainly on long-acting bronchodilators, which cannot target the pathogenic mechanisms of chronic inflammation in COPD. New pharmaceutical therapies for the inflammatory processes of COPD are urgently needed. Several anti-inflammatory targets have been identified based on increased understanding of the pathogenesis of COPD, which raises new hopes for targeted treatment of this fatal respiratory disease. In this review, we discuss the recent advances in bioactive low-molecular-weight drugs (LMWDs) for the treatment of COPD and, in addition to the first-line drug bronchodilators, focus particularly on low-molecular-weight anti-inflammatory agents, including modulators of inflammatory mediators, inflammasome inhibitors, protease inhibitors, antioxidants, PDE4 inhibitors, kinase inhibitors, and other agents. We also provide new insights into targeted COPD treatments using LMWDs, particularly small-molecule agents. FAU - Ti, Huihui AU - Ti H AD - Key Laboratory of Molecular Target & Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital , Guangzhou Medical University , Guangzhou 511436 , P. R. China. FAU - Zhou, Yang AU - Zhou Y AD - Key Laboratory of Molecular Target & Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital , Guangzhou Medical University , Guangzhou 511436 , P. R. China. AD - Division of Theoretical Chemistry and Biology, School of Biotechnology , Royal Institute of Technology (KTH) , AlbaNova University Center , Stockholm SE-100 44 , Sweden. FAU - Liang, Xue AU - Liang X AD - Key Laboratory of Molecular Target & Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital , Guangzhou Medical University , Guangzhou 511436 , P. R. China. FAU - Li, Runfeng AU - Li R AD - State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital , Guangzhou Medical University , Guangzhou 510120 , P. R. China. FAU - Ding, Ke AU - Ding K AUID- ORCID: 0000-0001-9016-812X AD - International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy , Jinan University , Guangzhou 510632 , P. R. China. AD - State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital , Guangzhou Medical University , Guangzhou 510120 , P. R. China. FAU - Zhao, Xin AU - Zhao X AUID- ORCID: 0000-0002-6659-3748 AD - Key Laboratory of Molecular Target & Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital , Guangzhou Medical University , Guangzhou 511436 , P. R. China. AD - School of Life Sciences , The Chinese University of Hong Kong , Shatin, N.T. , Hong Kong SAR 999077 , P. R. China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20190212 PL - United States TA - J Med Chem JT - Journal of medicinal chemistry JID - 9716531 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Antioxidants) RN - 0 (Bronchodilator Agents) RN - 0 (Enzyme Inhibitors) SB - IM MH - Animals MH - Anti-Inflammatory Agents/chemistry/*therapeutic use MH - Antioxidants/chemistry/*therapeutic use MH - Bronchodilator Agents/chemistry/*therapeutic use MH - Enzyme Inhibitors/chemistry/*therapeutic use MH - Humans MH - Molecular Weight MH - Pulmonary Disease, Chronic Obstructive/*drug therapy EDAT- 2019/01/27 06:00 MHDA- 2020/06/23 06:00 CRDT- 2019/01/26 06:00 PHST- 2019/01/27 06:00 [pubmed] PHST- 2020/06/23 06:00 [medline] PHST- 2019/01/26 06:00 [entrez] AID - 10.1021/acs.jmedchem.8b01520 [doi] PST - ppublish SO - J Med Chem. 2019 Jul 11;62(13):5944-5978. doi: 10.1021/acs.jmedchem.8b01520. Epub 2019 Feb 12.